RECRUITINGOBSERVATIONAL
Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
Epigenetics and Prevention of Non-communicable Diseases in Kazakhstan: a Personalized Approach and Biological Age Prediction
About This Trial
This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.
Who May Be Eligible (Plain English)
Who May Qualify:
- Adults aged 18 to 69 years.
- Residents of 17 regions of Kazakhstan.
- Willingness to participate and provide willing to sign a consent form.
Who Should NOT Join This Trial:
- Age less than 18 years old or over 69 years old.
- Failure to provide willing to sign a consent form or incomplete participation in data collection procedures.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Adults aged 18 to 69 years.
* Residents of 17 regions of Kazakhstan.
* Willingness to participate and provide informed consent.
Exclusion Criteria:
* Age less than 18 years old or over 69 years old.
* Failure to provide informed consent or incomplete participation in data collection procedures.
Treatments Being Tested
OTHER
Genetic: DNA analysis
Investigation of telomere length (TL) and DNA methylation level analysis
Locations (1)
Asfendiyarov Kazakh National Medical University
Almaty, Kazakhstan, Kazakhstan